136 related articles for article (PubMed ID: 708086)
1. [Experimental toxicological and pharmacodynamic studies of a triple drug association (adrenaline, atropine and papaverine) with anti-bronchospastic activity].
Lampa E; Rossi F; Rosatti F; Vacca C; Giordano L; Del Vecchio F; Alise G; Di Tonto B
Arch Sci Med (Torino); 1978; 135(3):327-50. PubMed ID: 708086
[TBL] [Abstract][Full Text] [Related]
2. [Bronchial asthma and experimental evaluation of the antibronchospastic action of adrenaline, atropine and papaverine alone and in combinations].
Marmo E; Rossi F; Lampa E; Giordano L; Rosatti F
Arch Monaldi; 1976; 31(3):211-32. PubMed ID: 1027386
[No Abstract] [Full Text] [Related]
3. [Clinico-instrumental evaluation of the changes induced in respiratory function by inhalation of a spray of adrenaline-atropine-papaverine].
Galluppi F; Garagnani C
Minerva Med; 1969 Nov; 60(95):4746-9. PubMed ID: 5357314
[No Abstract] [Full Text] [Related]
4. Pharmacological studies in animals of beta-hydroxyethyltheophylline, the major metabolite of doxofylline in humans.
Franzone JS; Cirillo R; Reboani MC
Methods Find Exp Clin Pharmacol; 1991 May; 13(4):289-99. PubMed ID: 1652045
[TBL] [Abstract][Full Text] [Related]
5. [Specific and aspecific activity of an antihistaminic of the H1 type: HC 20-511 or ketothiphen (benzo-cyclohepta-thiophenone derivative)].
Lampa E; Apolito A; Russo G; Pedone P; Alise G
Boll Chim Farm; 1977 Nov; 116(11):644-63. PubMed ID: 28130
[No Abstract] [Full Text] [Related]
6. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
Osada E; Murai T; Ishizaka Y; Sanai K
Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
[TBL] [Abstract][Full Text] [Related]
7. Some pharmacological properties of terbutaline (INN), 1-(3,5-dihydroxyphenyl)-2-(T-butylamino)-ethanol. A new sympathomimetic beta-receptor-stimulating agent.
Persson H; Olsson T
Acta Med Scand Suppl; 1970; 512():11-9. PubMed ID: 4396159
[No Abstract] [Full Text] [Related]
8. Studies on tetrahydroisoquinolines (THI). VI. Effects of trimetoquinol on tracheal and some other smooth muscles.
Kiyomoto A; Iwasawa Y; Harigaya S
Arzneimittelforschung; 1970 Jan; 20(1):46-52. PubMed ID: 4392500
[No Abstract] [Full Text] [Related]
9. Evaluation of dimethyl sulfoxide as a solvent in pharmacological experiments.
Varma RK; Kaushal R; Thomas GP; Junnarkar AY; Singh PP; Tripathi RM
Indian J Exp Biol; 1987 Nov; 25(11):758-60. PubMed ID: 3452597
[No Abstract] [Full Text] [Related]
10. [On the pharmacology of new benzyl- and chlorobenzylthia-alpha-pyrones].
Kretzschmar C; Hoffmann H; Splinter FK
Acta Biol Med Ger; 1968; 21(3):359-65. PubMed ID: 5705042
[No Abstract] [Full Text] [Related]
11. [Pharmacodynamic study of a new antiasthmatic drug. Salbutamol].
Foussard-Blanpin O; Narcisse G
Therapie; 1971; 26(6):1081-96. PubMed ID: 4401716
[No Abstract] [Full Text] [Related]
12. [Spasmolytic effect of 5,5-diphenyl-2-(2'-piperidino-ethyl)-1,3-dioxclan-4-one HCl, a new spasmolytic].
Mörsdorf K; Wengenroth H; Pailer M
Arzneimittelforschung; 1969 Nov; 19(11):1855-60. PubMed ID: 4391791
[No Abstract] [Full Text] [Related]
13. [PHARMACOLOGICAL STUDY ON PANAX GINSEG].
KITAGAWA H; IWAKI R
Nihon Yakurigaku Zasshi; 1963 Sep; 59():348-54. PubMed ID: 14092710
[No Abstract] [Full Text] [Related]
14. Sulfonyliminoimidazolidines, a new class of oral hypoglycemic agents. 4. Toxicity and general pharmacology of 1-[p-[2-(crotonylamino)-ethyl]-phenylsulfonyl]-3-cyclohexy l-2-imino- imidazolidine (CGP 11 112).
Märki F; Büch O; Delini-Stula A; Kraetz J; Petermann H; Radeke E; Schweizer A; Thomann P; Truog A
Arzneimittelforschung; 1984; 34(3):247-52. PubMed ID: 6539603
[TBL] [Abstract][Full Text] [Related]
15. Fat embolism: an experimental study (II). Evaluation of smooth muscle relaxants in its treatment.
Sachdeva HS; Sachdeva KC; Chakravarti RN
Am Surg; 1969 Apr; 35(4):257-64. PubMed ID: 4304663
[No Abstract] [Full Text] [Related]
16. [Antiserotonin action of several pharmacological substances on the vessels of the lungs and bronchi].
Zaslavskaia RM
Kardiologiia; 1969 Jun; 9(6):107-11. PubMed ID: 4389996
[No Abstract] [Full Text] [Related]
17. [Pharmacological and toxicological characterization of a multicomponent preparation in the treatment of circulatory disorders].
Marchetti G; Wagener HH
Arzneimittelforschung; 1974 Jan; 24(1):57-69. PubMed ID: 4150406
[No Abstract] [Full Text] [Related]
18. Pharmacological investigations of the essential oil of Colubrina asiatica.
Kar A; Menon MK; Chauhan CS
Planta Med; 1970 May; 18(3):222-6. PubMed ID: 4393339
[No Abstract] [Full Text] [Related]
19. [Pharmacological study of pipratecol (JP 711) and of a pharmaceutical combination raubasine-JP 711].
Laubie M; Le Douarec JC
Arzneimittelforschung; 1969 Nov; 19(11):1820-6. PubMed ID: 4391788
[No Abstract] [Full Text] [Related]
20. [Pharmacodynamic properties of 1-(2'-piperidine-ethyl)-4,4-bis-(para-methoxy-phenyl)-2,5-imidazolidinedione-chlorhydrate (I. 255). Studies of the effect on musculature of intestine gallbladder, uterus, bladder and trachea in vitro].
Marmo E; Annunziata A
Arzneimittelforschung; 1970 Feb; 20(2):277-81. PubMed ID: 4392558
[No Abstract] [Full Text] [Related]
[Next] [New Search]
